Lockheed Martin prepares for Precision Strike Missile take off
Lockheed Martin is revving up to begin flight testing its solution for the US Army's new Precision Strike Missile (PrSM) weapon.
Under 36-month risk reduction contracts, Lockheed Martin and Raytheon are out to replace the Army Tactical Missile System (ATACMS).
Their challenge? Extend the missile range from 60km out to 499km and equip a high-mobility artillery rocket system (HIMARS) with two weapons and the M270 family of launchers with four.
Not to be confused with the army's top modernisation priority, the service changed the name of its Long Range Precision Fires (LRPF) programme to PrSM.
A Lockheed Martin
Already have an account? Log in
Want to keep reading this article?
More from Land Warfare
-
DSEI 2025: OpenWorks launches new system for on-the-move targeting
Vision Pace uses OpenWorks’ artificial intelligence (AI) classifiers and trackers to detect, track and identify multiple targets in land and naval applications for air defence.
-
DSEI 2025: Patria’s FAMOUS becomes TRACKX with production ready before end of 2027
The first two Technology Test Beds (TTBs) have been completed and put through a series of company trials including sand, snow, swamp, forest and tarmac.
-
DSEI 2025: General Dynamics firms up Ajax for potential British Army IFV requirement
Following the cancellation of the Lockheed Martin UK Warrior Capability Sustainment Programme (WCSP), the British Army will have a serious capability gap when the current Warrior infantry fighting vehicle (IFV) is soon phased out of service.
-
DSEI 2025: Trials completed for new version of Tridon air defence gun
Less than two years ago, Sweden’s BAE Systems Bofors announced it was developing a new 40mm short-range air defence system using internal research and development funding, calling it the Tridon Mk2.
-
DSEI 2025: Rheinmetall adds Lockheed Martin missile punch to Fuchs vehicle
The combination of the Rheinmetall platform with Lockheed Martin missiles is seen as the bringing together of mature systems to provide a capability in the medium term, but trials could be as long as 12 months away.